National Guideline Clearinghouse | Radionuclide therapy for neuroendocrine malignancies.
Cancer Care Ontario
December 23, 2013
This is the current release of the guideline.
The EVIDENCE-BASED SERIES report, initially the full original Guideline, over time will expand to contain new information emerging from reviewing and updating activities.
Please visit the Cancer Care Ontario Web site for details on any new evidence that has emerged and implications to the guidelines.